Biblio

Found 1 results

Filters: Keyword is Xenograft Model Antitumor Assays [Clear All Filters]

2022

Qureshy Z, Li H, Zeng Y, Rivera J, Cheng N, Peterson CN, Kim M-O, Ryan WR, Ha PK, Bauman JE et al.. 2022. STAT3 Activation as a Predictive Biomarker for Ruxolitinib Response in Head and Neck Cancer.. Clin Cancer Res. 28(21):4737-4746.